Carl Zeiss eyes enhanced revenues from India ops

Carl Zeiss, the German manufacturer of optical systems, industrial measurements and medical devices is confident of scaling up exports of spectacle lenses from its Bangalore lab, buoyed by initial success in West Asian markets.

“We started exporting on a trial basis last July to the Middle East (West Asia); the business is stable since October. We now want to gradually expand it to other Asian countries,” president and chief executive officer of Vision Care Group at Carl Zeiss, Raymund Heinen told Deccan Herald.

The company's India operations contributed about 100 million euros in revenues last year to its global turnover of about $4.2 billion euros, he added.

Besides, the company is also optimistic of scaling up its revenues from medical and industrial measurement business segments. “In India, our maximum revenues currently come from medical technology (devices) because India has invested a lot in healthcare. The second biggest source is industrial measurement equipment, especially in automobile sector,” he said. While acknowledging that the Indian economy has slowed down in the recent past, Heinen said that it is still a growing market. 

Globally, Carl Zeiss, derives about 25 per cent of its revenues each from its medical technology, semiconductor technology and microscopy & industrial measurement segments. Spectacle lenses (20 per cent) and camera lenses (5 per cent) account for the rest, Heinen said.

On the profile of its 60-member Bangalore lab, division manager Marc Wawerla said, “All of them are Indians, I am the only non-Indian.”